Logo
x

Search category

Subscribe Now

Injection

Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk Acute Myeloid Leukemia

Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk...

  • July 9, 2021
Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk Acute Myeloid Leukemia

Jazz's Vyxeos (daunorubicin and cytarabine liposome) for Injection Receives Health Canada Approval for the Treatment of High-risk...

  • July 9, 2021
Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Carcinoma

Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Car...

  • June 29, 2021
Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Carcinoma

Innovent's Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) Receive the NMPA's Approval as 1L Therapy for Hepatocellular Car...

  • June 29, 2021
Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer

Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer

  • May 27, 2021
Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer

Lantheus' Pylarify (piflufolastat F 18) Injection Receives the US FDA's Approval for the Treatment of Prostate Cancer

  • May 27, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.